Do the TPP and the proposed India-EU trade deal extend protection of IPR, delaying generic competition for life-saving drugs and keeping their prices high? While these and other possible implications for Indian consumers and pharma companies become clearer over time, India must robustly engage with the debate on trade deals and public interest
Although it is too soon to comprehensively analyse the Trans-Pacific Partnership agreement of October 5, it is worth assessing what is known. Here are the facts, the controversies, the assessments, and the implications for countries that are not part of the agreement, especially India.
External integration—which the Trans Pacific Partnership and the Regional Comprehensive Economic Partnership will generate—has policy implications that India must manage well and quickly. As a first step, India can introduce the GST, among other measures, in order to become a more unified domestic economy.
Dr. Kanti Bajpai, Professor, Lee Kuan Yew School of Public Policy, Singapore, talks about the reasons for the breakdown in the India-U.S. bilateral. In an interview to Gateway House, he also examines the recent strides taken in deepening India-Japan ties and the new government’s priorities in East Asia
EconomyWatch republished an article written for Gateway House by Dr. Dan Steinbock on the Trans Pacific Partnership. Dr Steinbock says that while joining the TPP will energize India's trade, negotiating an entry may need concessions which may not be in its interests
The U.S. government shutdown and President Obama’s absence gave China immense diplomatic and political space at the APEC and East Asia Summit meetings. China’s declaration of a “de-Americanised” world may be premature but the crumbling old order is doing little to dispel this notion